COVID – 19 | Vaccination Update – Day 623

ad
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 218.66 Crore (2,18,66,00,135today. More than 11 lakh (11,88,205) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10415200
2nd Dose 10118871
Precaution Dose 7027087
FLWs 1st Dose 18436820
2nd Dose 17716501
Precaution Dose 13657490
Age Group 12-14 years 1st Dose 41029677
  2nd Dose 31785799
Age Group 15-18 years 1st Dose 61945792
  2nd Dose 53075775
Age Group 18-44 years 1st Dose 561281601
2nd Dose 515805030
Precaution Dose 96066545
Age Group 45-59 years 1st Dose 204030891
2nd Dose 196970741
Precaution Dose 48953012
Over 60 years 1st Dose 127669738
2nd Dose 123144447
Precaution Dose 47469118
Cumulative 1st dose administered 1024809719
Cumulative 2nd dose administered 948617164
Precaution Dose 213173252
Total 2186600135

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 30th September, 2022 (623rd Day)
HCWs 1st Dose 14
2nd Dose 160
Precaution Dose 5556
FLWs 1st Dose 31
2nd Dose 219
Precaution Dose 9831
Age Group 12-14 years 1st Dose 12470
  2nd Dose 36038
Age Group 15-18 years 1st Dose 3196
  2nd Dose 15863
Age Group 18-44 years 1st Dose 9690
2nd Dose 45392
Precaution Dose 650826
Age Group 45-59 years 1st Dose 1898
2nd Dose 9864
Precaution Dose 264464
Over 60 years 1st Dose 1241
2nd Dose 6495
Precaution Dose 114957
Cumulative 1st dose administered 28540
Cumulative 2nd dose administered 114031
Precaution Dose 1045634
Total 1188205

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply